These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 28361606)

  • 21. Targeted Drug Delivery Systems and Their Therapeutic Applications in Cancer and Immune Pathological Conditions.
    Iqbal J; Anwar F; Afridi S
    Infect Disord Drug Targets; 2017; 17(3):149-159. PubMed ID: 28595539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards targeted cancer therapy: Aptamer or oncolytic virus?
    Tan KX; Danquah MK; Sidhu A; Ongkudon CM; Lau SY
    Eur J Pharm Sci; 2017 Jan; 96():8-19. PubMed ID: 27593990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in "smart" delivery systems for extended drug release in cancer therapy.
    Kalaydina RV; Bajwa K; Qorri B; Decarlo A; Szewczuk MR
    Int J Nanomedicine; 2018; 13():4727-4745. PubMed ID: 30154657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacokinetic advantages of new drug delivery methods for the treatment of liver tumours.
    Anderson JH; Warren HW; McArdle CS
    Clin Pharmacokinet; 1994 Sep; 27(3):191-201. PubMed ID: 7988101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Smart Cancer Cell Targeting Imaging and Drug Delivery System by Systematically Engineering Periodic Mesoporous Organosilica Nanoparticles.
    Lu N; Tian Y; Tian W; Huang P; Liu Y; Tang Y; Wang C; Wang S; Su Y; Zhang Y; Pan J; Teng Z; Lu G
    ACS Appl Mater Interfaces; 2016 Feb; 8(5):2985-93. PubMed ID: 26767305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smart blood cell and microvesicle-based Trojan horse drug delivery: Merging expertise in blood transfusion and biomedical engineering in the field of nanomedicine.
    Wu YW; Goubran H; Seghatchian J; Burnouf T
    Transfus Apher Sci; 2016 Apr; 54(2):309-18. PubMed ID: 27179926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Problems of delivery of monoclonal antibodies. Pharmaceutical and pharmacokinetic solutions.
    Reilly RM; Sandhu J; Alvarez-Diez TM; Gallinger S; Kirsh J; Stern H
    Clin Pharmacokinet; 1995 Feb; 28(2):126-42. PubMed ID: 7736688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual-Targeted Phototherapeutic Agents as Magic Bullets for Cancer.
    Wen Y; Schreiber CL; Smith BD
    Bioconjug Chem; 2020 Mar; 31(3):474-482. PubMed ID: 31940166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-targeted and multi-stimuli responsive drug delivery system for near-infrared light induced chemo-phototherapy and photoacoustic tomography.
    Feng Q; Zhang Y; Zhang W; Shan X; Yuan Y; Zhang H; Hou L; Zhang Z
    Acta Biomater; 2016 Jul; 38():129-42. PubMed ID: 27090593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards MRI-controlled ferromagnetic and MC-1 magnetotactic bacterial carriers for targeted therapies in arteriolocapillar networks stimulated by tumoral angiogenesis.
    Martel S
    Conf Proc IEEE Eng Med Biol Soc; 2006; 2006():3399-402. PubMed ID: 17947026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The potential legacy of cancer nanotechnology: cellular selection.
    Patra HK; Turner AP
    Trends Biotechnol; 2014 Jan; 32(1):21-31. PubMed ID: 24246361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel antibodies as anticancer agents.
    Zafir-Lavie I; Michaeli Y; Reiter Y
    Oncogene; 2007 May; 26(25):3714-33. PubMed ID: 17530025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The return of Ehrlich's 'Therapia magna sterilisans' and other Ehrlich concepts?. Series of papers honoring Paul Ehrlich on the occasion of his 150th birthday.
    Sörgel F
    Chemotherapy; 2004 Apr; 50(1):6-10. PubMed ID: 15084798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paul Ehrlich's magic bullets.
    Schwartz RS
    N Engl J Med; 2004 Mar; 350(11):1079-80. PubMed ID: 15014180
    [No Abstract]   [Full Text] [Related]  

  • 35. Oligo-branched peptides for tumor targeting: from magic bullets to magic forks.
    Falciani C; Pini A; Bracci L
    Expert Opin Biol Ther; 2009 Feb; 9(2):171-8. PubMed ID: 19236247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer 'chemotherapia specifica' ninety years after Paul Ehrlich.
    Shukla SK; Petrucci F; Caimi S; Alimonti A; Cusumano R
    Chemotherapy; 2007; 53(5):309-12. PubMed ID: 17728538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyaluronic acid-decorated graphene oxide nanohybrids as nanocarriers for targeted and pH-responsive anticancer drug delivery.
    Song E; Han W; Li C; Cheng D; Li L; Liu L; Zhu G; Song Y; Tan W
    ACS Appl Mater Interfaces; 2014 Aug; 6(15):11882-90. PubMed ID: 25000539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Swallowable smart pills for local drug delivery: present status and future perspectives.
    Goffredo R; Accoto D; Guglielmelli E
    Expert Rev Med Devices; 2015; 12(5):585-99. PubMed ID: 26118473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumour-targeted drug and gene delivery: principles and concepts.
    Cassidy J; Schätzlein AG
    Expert Rev Mol Med; 2004 Sep; 6(19):1-17. PubMed ID: 15387893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contact-facilitated drug delivery with Sn2 lipase labile prodrugs optimize targeted lipid nanoparticle drug delivery.
    Pan D; Pham CT; Weilbaecher KN; Tomasson MH; Wickline SA; Lanza GM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(1):85-106. PubMed ID: 26296541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.